|
Market Closed -
OTC Markets
15:12:31 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0650 USD | -4.41% |
|
+664.71% | -78.75% |
| 04-15 | CS Diagnostics Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-14 | CS Diagnostics Corp. Auditor Raises 'Going Concern' Doubt | CI |
Company Valuation: CS Diagnostics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Market Cap 1 | 0.3951 | 150.6 | 76.47 |
| Change | - | 38,005.96% | -49.21% |
| Enterprise Value (EV) 1 | 0.3747 | 150.6 | 76.47 |
| Change | - | 40,076.48% | -49.21% |
| P/E | -2,525x | 232,000x | 1,077x |
| PBR | 0.11x | 0.32x | 0.15x |
| PEG | - | -2,263x | 0x |
| Capitalization / Revenue | 3.13x | 1,357x | 375x |
| EV / Revenue | 2.97x | 1,357x | 375x |
| EV / EBITDA | - | - | - |
| EV / EBIT | -17x | 197,840x | 1,074x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.000198 | 0.000005 | 0.000284 |
| Distribution rate | - | - | - |
| Net sales 1 | 0.126 | 0.1109 | 0.204 |
| EBITDA | - | - | - |
| EBIT 1 | -0.022 | 0.000761 | 0.0712 |
| Net income 1 | -0.022 | 0.000761 | 0.0712 |
| Net Debt 1 | -0.0204 | -0.000501 | -0.006813 |
| Reference price 2 | 0.500000 | 1.160000 | 0.305900 |
| Nbr of stocks (in thousands) | 790 | 129,790 | 249,992 |
| Announcement Date | 7/29/25 | 7/29/25 | 4/15/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 2.12M | ||
| 27.63x | 3.84x | 14.83x | 2.64% | 169B | ||
| 18.25x | 3.37x | 12.04x | 3.26% | 110B | ||
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | ||
| 25.26x | 2.48x | 10.04x | 2.86% | 73.87B | ||
| 16.92x | 0.2x | 12.42x | 0.77% | 58.98B | ||
| 29.48x | 7.29x | 18.84x | 1.36% | 51.28B | ||
| 34.07x | 3.32x | 11.38x | 2.22% | 48.16B | ||
| 35.11x | 8.73x | 24.55x | -.--% | 40.84B | ||
| 34.3x | 6.01x | 18.87x | -.--% | 32.21B | ||
| Average | 26.94x | 4.38x | 15.30x | 1.6% | 69.02B | |
| Weighted average by Cap. | 25.35x | 3.98x | 14.47x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSDX Stock
- Valuation CS Diagnostics Corp.
Select your edition
All financial news and data tailored to specific country editions
















